Documents for Download
Registry for long-term follow-up of CML patients who discontinued Imatinib after Complete Cytogenetic Response
Information letter
(123KB)for the registry on patients who discontinued imatinib after CCR
1st Form
(74KB)(Baseline) time of diagnosis
2nd Form
(71KB)(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
3rd Form
(71KB)(Restart of Imatinib) (to be filled out at time of 1st restart of Imatinib and every 3 months thereafter)
4th Form
(62KB)(Therapeutic responses before the 1st disc. of I.) to be filled out every 3 months after diagnosis, but only as long as Imatinib was administered, otherwise refer to the 2nd Form